Roche | Zee News

Advertisement

Roche News

antibody therapy

28 May 2021

What is an antibody cocktail, is it effective against COVID-19, Zee explains

The antibody therapy is a cocktail of two monoclonal antibodies - Casirivimab-Imdevimab injection The therapy is most suited for "high-risk COVID-19 patients" who are within the first ten days of symptom onset Switzerland-based Roche has developed this antibody cocktail and launched it in the Indian market along with Cipla

24 May 2021

Roche, Cipla launch Antibody Cocktail for treatment of mild to moderate COVID

Roche, Cipla launch ‘Antibody Cocktail’ for COVID treatment The drug can be used to treat patients suffering mild to moderate symptoms The drug is priced at Rs 59,750 per dose

03 May 2020

Roche gets US FDA emergency use nod for coronavirus COVID-19 antibody test

Roche Holding AG received emergency use approval from the US Food and Drug Administration (FDA) for an antibody test to help determine if people have ever been infected with the coronavirus, the Swiss drugmaker said on Sunday.

16 Jun 2017

Cancer drug: SC allows Cipla to withdraw appeal against Roche

The Supreme Court on Friday allowed domestic drug manufacturer Cipla, which recently arrived at a settlement with Swiss pharma major Roche over a lung cancer drug, to withdraw its petition on the patent row.

12 Oct 2015

Roche launches new breast cancer drugs in India

Swiss drug major Roche has launched in India two new medicines for treating breast cancer claiming increased survival benefit and improved quality of life for patients.

Loading...

NEWS ON ONE CLICK